Evaluation of Hematological, Inflammatory and Coagulation Biomarkers as an Indicator of COVID-19 Severity

被引:0
|
作者
AYDIN, Nurten Nur [1 ]
AYDIN, Murat [1 ]
YILMAZ, Sibel I. B. A. [1 ]
机构
[1] Erzurum Reg Training & Res Hosp, Clin Infect Dis & Clin Microbiol, Erzurum, Turkiye
来源
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2023年 / 28卷 / 02期
关键词
COVID-19; Biomarker; Lymphocyte-CRP ratio (LCR); Fibrinogen-albumin ratio (FAR); DISEASE SEVERITY; PARAMETERS; INFECTION; MARKERS;
D O I
10.5578/flora.20239918
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: The aim of this study is to investigate the relationship between the severity of coronavirus disease-19 (COVID-19) with hematological, biochemical and coagulation parameters. Materials and Methods: This study included 277 hospitalized patients who were diagnosed with COVID-19 by realtime polymerase chain reaction (PCR) analysis of nasopharyngeal swab sample between January and May 2021. According to the World Health Organization (WHO) COVID-19 severity classification, patients were divided into two groups as mild/moderate group (non-severe) and severe/critical group (severe). Demographic data of the patients and laboratory parameters at the time of hospitalization were evaluated retrospectively. Results: The neutrophil count was significantly higher in the severe group (p= 0.021), while the lymphocyte and thrombocyte counts were significantly lower (p< 0.001, p= 0.031, respectively). Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, mean platelet volume-lymphocyte ratio were significantly higher in the severe group (p< 0.001, p= 0.001, p< 0.001, respectively), while lymphocyte-monocyte ratio was lower (p= 0.005). C-reactive protein (CRP), ferritin, D-dimer, fibrinogen and prothrombin time were significantly higher in the severe group (p< 0.001, p< 0.001, p= 0.004, p< 0.001, p= 0.033, respectively), albumin levels were lower (p< 0.001). Blood urea nitrogen-albumin ratio, CRP-albumin ratio, fibrinogen-albumin ratio (FAR) were significantly higher and lymphocyte-CRP ratio (LCR) was lower in the severe group (p< 0.001 for each). The area under the curve (AUC) of the LCR value was 0.747 in ROC analyzes performed between both groups. When the LCR cut-off value was 0.14, 86.9% sensitivity and 52.9% specificity were detected. When the cut-off value of CRP was 13.2 mg/L, 0.724 AUC was detected with 82.0% sensitivity and 57.1% specificity. FAR showed 59.3% sensitivity and 72.2% specificity at a cut-off value of 12.17 (AUC= 0.696). Ferritin showed 72.7% sensitivity and 55.6% specificity at a cut-off value of 189 ng/mL (AUC= 0.691). A strong correlation was found between FAR and CRP in the correlation analysis (r= 0.724, p< 1000). In addition, a relationship was found between FAR and ferritin (r= 0.454, p< 1000). Conclusion: These laboratory parameters can be used as suitable biomarkers to determine the severity of COVID-19. These can help clinicians identify potentially serious cases at an early stage and enable early medical management.
引用
收藏
页码:188 / 197
页数:10
相关论文
共 50 条
  • [41] Role of hematological parameters in the stratification of COVID-19 disease severity
    Taj, Sadia
    Kashif, Ambreen
    Fatima, Syeda Arzinda
    Imran, Sheharbano
    Lone, Ayaz
    Ahmed, Qasim
    ANNALS OF MEDICINE AND SURGERY, 2021, 62 : 68 - 72
  • [42] Hematological Findings and Clinical Severity in Pediatric Patients with COVID-19
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (04) : 329 - 329
  • [43] Study of biomarkers to determine severity and lung damages in COVID-19 patients
    Rosyid, Alfian Nur
    Puspitasari, Arina Dery
    Effendy, Wiwin Is
    Setiawan, Herley Windo
    Bakhtia, Arief
    Marhana, Isnin Anang
    Sensusiati, Anggraini Dwi
    Nugraha, Jusak
    Ami, Muhammad
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (09): : 1320 - 1328
  • [44] Fucosylated N-glycans as early biomarkers of COVID-19 severity
    Paton, Beatrix
    Herrero, Pol
    Peraire, Joaquim
    del Pino, Antoni
    Chafino, Silvia
    Martinez-Picado, Javier
    Gomez-Bertomeu, Frederic
    Rull, Anna
    Canela, Nuria
    Suarez, Manuel
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] Novel inflammatory biomarkers in the prognosis of COVID-19
    Zhan, Kegang
    Wang, Luhan
    Lin, Hao
    Fang, Xiaoyu
    Jia, Hong
    Ma, Xiangyu
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2023, 17
  • [46] Proteomic profiling identifies biomarkers of COVID-19 severity
    Harriott, Noa C.
    Ryan, Amy L.
    HELIYON, 2024, 10 (01)
  • [47] COVID-19: A collision of complement, coagulation and inflammatory pathways
    Chauhan, Anoop J.
    Wiffen, Laura J.
    Brown, Thomas P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2110 - 2117
  • [48] Laboratory biomarkers associated with COVID-19 severity and management
    Keddie, S.
    Ziff, O.
    Chou, M. K. L.
    Taylor, R. L.
    Heslegrave, A.
    Garr, E.
    Lakdawala, N.
    Church, A.
    Ludwig, D.
    Manson, J.
    Scully, M.
    Nastouli, E.
    Chapman, Md
    Hart, M.
    Lunn, Mp
    CLINICAL IMMUNOLOGY, 2020, 221
  • [49] Red blood cell distribution width: A severity indicator in patients with COVID-19
    Wang, Zhong-hua
    Fu, Bing-qi
    Lin, Ying-wen
    Wei, Xue-biao
    Geng, Heng
    Guo, Wei-xin
    Yuan, Hui-qing
    Liao, You-wan
    Qin, Tie-he
    Li, Fei
    Wang, Shou-hong
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 2133 - 2138
  • [50] Dynamic Assessment of Hematological Parameters as Predictive Biomarkers for Disease Severity and Prognosis in COVID-19 Patients: A Longitudinal Study
    Patange, Aparna P.
    V. Desai, Jabbar
    Pujari, Bhupal
    Marwah, Aparna
    Dey, Animesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)